Registration Options

Activity Dates: 05/31/2023 - 05/15/2026

Target Audience

We invite you to participate in this online course if you are a pharmacist, nurse, or other health care professional interested in administering and/or learning more about psychotropic long-acting injectables for patients living with serious mental illness or substance use disorders.

Session Summary

This webinar focuses on important factors related to use of LAIs for substance use disorders, such as target patient populations, indications, product preparation, dosing, administration techniques, adverse effects, storage requirements, and monitoring recommendations.

 
This is one of six modules in the Psychotropic LAI Training Program. Complete your complimentary registration now to access this module, 5 other ACPE approved modules, a LAI Pocket Guide, administration videos, and an Administrative Toolkit.
 

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Complete the pre-test before starting the activity.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Participants in this course must complete an examination and achieve a score of 70% or greater. Up to two exam attempts are provided to each participant. Successful completion of the course also requires the completion of a course evaluation. Upon successful completion, ACPE credit is reported immediately to CPE Monitor although transcripts can be retrieved by participants online at https://aapp.org/mycpnp/transcript/acpe.

Faculty Information and Disclosures

Learning Objectives

  1. Describe dosing and administration, including product preparation, for naltrexone long acting injectable (LAI) and buprenorphine LAI.
  2. Identify contraindications, warnings/precautions, common adverse effects and potential mitigation strategies for naltrexone LAI and buprenorphine LAI.
  3. Describe the storage requirements and stability data of naltrexone LAI and buprenorphine LAI.
  4. Outline a plan for monitoring and follow up of a patient receiving naltrexone LAI or buprenorphine LAI.

Continuing Education Credit and Disclosures

Activity Dates: 05/31/2023 - 05/15/2026
ACPE Contact Hours: 0.75
ACPE Number: 0284-0000-23-025-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.

Grant Support

This activity is supported by educational grants from Alkermes Inc., Indivior Inc., and Janssen Scientific Affairs, LLC.